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Gennline missense mutations within the coding region of the RET proto-oncogene have recently been 
described in patients with the dominantly inherited cancer syndromes, multiple endocrine neoplasia 
type 2a (MEN 2a) and familial medullary thyroid carcinoma (FMTC). To date, the sequence variations 
occur in RET exons 10 and 11 and alter highly conserved cysteine residues in the proposed extracel- 
Mar domain at codons 609,611,618,620, and 634. To expedite rapid screening of populations at risk 
of MEN 2a or FMTC, we developed a PCR-based denaturing gradient gel electrophoresis (DGGE) 
strategy that detects polymorphisms occurring at all five Cys codons in both RET exons using identical 
gel conditions. In this report, the screening results from DGGE analysis of 15 distinct MEN 2a and 
FMTC mutations are shown. Each mutation generated a clearly distinguishable and unique homo- and 
heteroduplex band pattern. Given the highly efficient, reproducible, and sensitive nature of this ap- 
proach, DGGE is particularly appropriate for rapid, large-scale screening of patients. Since prior 
knowledge of the RET mutation is unnecessary for analysis, DGGE is potentially valuable for distin- 
guishing germline from seemingly sporadic medullary thyroid cancer as well as identifying novel 
sequence changes. 8 1996 Wiley-Lis, Inc. 
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INTRODUCTION 
Multiple endocrine neoplasia type 2a (MEN 
2A) and familial medullary thyroid carcinoma 
(FMTC) are dominantly inherited cancer syn- 
dromes characterized by the occurrence of medul- 
lary thyroid carcinoma (MTC). Patients with 
MEN 2A also have a predisposition to the devel- 
opment of pheochromocytomas, parathyroid hy- 
perplasia, and Hirschsprung's disease (Decker, 
1992; Borst et al., 1995). Recently, germline mis- 
sense mutations within the coding region of the 
RET proto-oncogene, a putative transmembrane 
tyrosine kinase, have been described in family 
members affected with these cancer syndromes 
(Mulligan et al., 1993; Donis-Keller et al., 1993; 
Mulligan et al., 1994). To date, all reported mu- 
tations occur in RET exons 10 and l l  and involve 
codons specifying highly conserved cysteine resi- 
dues within the presumed extracellular domain of 
the receptor. Four of the five cysteines mutated in 
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these syndromes are 1oc.ated in RET exon 10 at 
codons 609, 611, 618, and 620 (Takahashi et al., 
1988; Takahashi et al., 1989). The most frequent 
events occur at the remaining codon 634 in exon 
11, accounting for approximately 84% of patients 
with MEN 2a and 50% of patients with FMTC 
(Mulligan et al., 1994). 
Identification of the responsible gene allowed us 
to develop a DNA-based screening strategy for rnu- 
tation detection to assist in the diagnosis of pa- 
tients at risk for MEN 2A or FMTC. Previously, 
testing for hereditary MTC was accomplished by 
measuring calcitonin levels after the intravenous 
injection of pentagastrin and/or calcium (Wells et 
al., 1978). This method of diagnosis is suboptimal 
for several reasons. First, due to delayed biochem- 
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ical penetrance, years of repeated testing may be 
required before the disease can be safely excluded. 
Furthermore, borderline results are difficult to in- 
terpret and family compliance with screening prob- 
lematic given the expensive and unpleasant nature 
of the pentagastrin testing. Finally, biochemical 
testing of all first-degree relatives in new cases of 
MTC to distinguish germline from sporadic disease 
is cumbersome and diffkult to accomplish. More 
recently, various DNA-based techniques have 
emerged to identify RET mutations including di- 
rect genomic sequencing, single-stranded confor- 
mational polymorphisms (SSCP), and restriction 
enzyme digestion analysis (Donis-Keller et al., 
1993; McMahon et al, 1994; Xue et al, 1994). 
However, these may not be the most efficient or 
accurate methods for mutational analysis. More- 
over, prior knowledge of the mutation may be 
necessary limiting test efficacy in prospective 
screening. Therefore, we have developed a highly 
reliable denaturing gradient gel electrophoresis 
(DGGE) strategy to expedite detection of the 
MEN 2alFMTC RET point mutations in exons 10 
and 11. Analysis by DGGE has been successful in 
our hands as a nonradioactive method for rapid, 
simultaneous screening of a large number of pa- 
tients and has replaced other DNA-based ap- 
proaches to diagnosis as well as biochemical testing 
in our patients at risk of hereditary MTC. 
MATERIALS AND METHODS 
Polymerase Chain Reaction 
Genomic DNA representing 15 distinct muta- 
tions at Cys codons 609, 611, 618, 620, and 634 
were analyzed. Polymerase chain reaction (PCR) 
amplification of RET exon 10 was performed using 
1 pg genomic DNA template, 2.2 pM each olig- 
onucleotide primer, 200 pM each dNTP, 1.25 U 
Taq DNA polymerase (Gibco BRL, Gaithersburg, 
MD), 10 mM Tris (pH 8.3), 50 mM KCl, 2.0 mM 
MgC1, in a total volume of 50 p1. Conditions for 
amplification consisted of 35 cycles at 95°C for 1 
min (denaturation), 72°C for 1 min (annealing 
and extension), followed by a single denaturing 
and annealing step at 100°C for 10 min using an 
automated thermocycler (MJ Research, Water- 
town, MA). Expected product size is 216 bp. The 
following primers were chosen from intronic se- 
quences flanking the introdexon boundaries of 
exon 10 after a melting profile analysis by Melt87 
(Lerman and Silverstein 1987), and included a 
GC-clamp: 5'GCGCCCCCCGCCCCCGCCC- 
CGCCCGCCGCGGCGCCCCAGGAGGCTG- 
AC; TG3' (5 'primer) and 5'CGTGGTGGTC- 
CCGGCCGCC3' (3 'primer). 
For amplification of exon 11, primers 5'C- 
CTCACACCACCCCCACCCA3' (5 'primer) 
and "(GC) ,5GTCCAGCGAGGGCCGGCG- 
GG3' (3' primer) were selected from sequences 
flanking Cys codon 634 following MELT87 anal- 
ysis. Amplification of the 268 bp fragment was 
performed using 1 p g  genomic DNA, 2.2 p M  each 
primer, 200 pM each dNTP, 1.25 units Taq poly- 
merase, 10 mM Tris (pH 8.3), 50 mM KC1, 1.5 
mhl MgCl, and 10% DMSO in a final volume of 
50 p1. Thermal cycling conditions consisted of 35 
cycles of denaturation at 95°C for 1 min, annealing 
at 62°C for 30 sec, and extension at 72°C for 1 min 
(MJ Research, Watertown, MD). Following each 
amplification, samples were heated to 100°C for 10 
min and allowed to cool to room temperature to 
fac 11 i tate heteroduplex formation. 
Denaturing Gradient Gel Electrophoresis 
DGGE analysis was carried out on a 1-mm-thick 
9% acrylamide gel (acrylamide: bis-acrylamide 
20:l) with a 50-80% linear gradient of denatur- 
ants (100% = 7M urea, 40% (vlv) formamide) in 
1 X TAE buffer (40 mM Tris acetate, 20 mM so- 
dium acetate, l mM EDTA at pH 7.8). Gel was 
overlayed with a 6% polyacrylamide stacker (acry- 
1aniide:bis-acrylamide 30: 1) containing 1 x TAE. 
Amplified PCR fragments were electrophoresed at 
65'C and 17 mA/gel for 18 hr (Hoefer Scientific 
Instruments, San Francisco, CA) with recircula- 
tion of buffer from the lower to upper electrode 
chamber and ethidium bromide stained (10 min) 
prior to visualization. 
RESULTS 
Figure 1 illustrates the DGGE findings of 10 of 
the reported MEN 2a and FMTC RET mutations 
in (exon 10. The analysis includes each of the four 
cysteine codons within the coding sequence of 
exon 10 implicated in the pathogenesis of MEN 2a 
and FMTC. The mutations shown occur at base 
positions 2021, 2028, 2047, 2048, 2053, and 2054 
and involve Cys codons 609, 611, 618, and 620. 
Shown in Figure 2 are the results of DGGE analysis 
from five distinct Cys codon 634 mutations involv- 
ing missense changes at nucleotides 2095, 2096, or 
2097. In all cases, DGGE of the PCR-amplified 
fragment produced clear, sharply distinguishable 
and unique mutant homo- and heteroduplex band 
patterns specific for each point mutation. Normal 
controls showed the expected single banding pat- 
tern reflecting the homozygous genotype. Muta- 
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FIGURE 1. DGGE analysis of PCR amplified fragments representing 10 different missense mutations at 
Cys codons 609, 611, 618, and 620 in exon 10 of the RET proto-oncogene and normal sequenced 
controls. Missense mutation and corresponding codon relative to the full length RET coding sequence 
are as indicated. Unique mutant and homo- and heteroduplex bands were observed in each case. 
Wild-type homoduplex is indicated by the arrow. 
tions involving base pair transversions as well as 
transitions were successfully delineated. Normal 
and mutant homoduplex bands were superimposed 
in the TGC-to-TGG transversion at codons 61 1 
and 634. Therefore, final classification of muta- 
tions in these cases relied on differences in the 
heteroduplex patterns. The DGGE results were 
consistently and easily reproducible in separate ex- 
periments under identical PCR and gel conditions. 
The DGGE analysis of RET exon 10 in a seg- 
ment of a large MEN 2A kindred is shown in Fig- 
ure 3. The mutant heteroduplex banding pattern is 
clearly present in all affected patients whereas the 
DGGE wild-type conformation, characterized by a 
single band, is seen in those unaffected with the 
disease. Direct DNA sequencing of mutants dem- 
onstrated a heterozygous base change of adenine 
for thymine at nucleotide 2047 resulting in a serine 
for cysteine substitution at codon 618 (not 
shown). All affected patients have undergone thy- 
roidectomy with histological evidence of MTC. 
The normal status of individuals at risk for MTC in 
this family has been verified biochemically by the 
pentagastrin provocative testing. 
DISCUSSION 
The DNA samples analyzed collectively repre- 
sent 15 of the reported missense mutations involv- 
ing RET exons 10 and 11 in MEN 2A and FMTC. 
Our findings demonstrate that each point muta- 
tion reliably generated a DGGE polymorphism. 
Furthermore, DGGE of leach mutation throughout 
this region of RET displayed a unique mutant 
homo- and heteroduplex banding pattern accu- 
rately reflecting the hetlerozygous point mutation. 
Final characterization of the mutations relied on 
direct comparison with known mutants and overall 
banding pattern. DGGEI is a sensitive and highly 
reproducible technique that separates double- 
stranded DNA fragment under denaturing condi- 
tions based on differing melting characteristics 
(Fischer and Lerman, 1983). To ensure detection 
of base changes in the region of the lowest melting 
domain, a GC clamp was included in the sequence 
to be amplified. Given the high degree of resolu- 
tion and reproducible nature of these results, we 
believe that all codon 6C9, 61 1, 618, 620, and 634 
mutations can be identified, as well as novel mu- 
tations at other positions in patients with familial 
or seemingly sporadic MTC or pheochromocy- 
toma. 
Other techniques have been used to detect ger- 
mline RET mutations including direct DNA se- 
quencing, restriction enzyme digestion, and SSCP 
analysis, however, the DGGE strategy confers sev- 
eral advantages in this setting. First, because of the 
relatively few manipulations, this approach per- 
mits rapid turnover of results making it amenable 
to mass screening of patients. Second, it does not 
require the use of radioisotopes. Third, the proce- 
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FIGURE 2. DGGE gel analysis of PCR-amplified fragment!; representing five different missense muta- 
tions at Cys codon 634 (nucleotides 2095,2096, and 2097) in exon 11 of the RET proto-oncogene and 
normal sequenced and ciinical controls. Missense mutation and corresponding basepair position 
relative to the RET coding sequence are as indicated. Nucleotides are numbered from the transcrip- 
tion start site as defined by Kwok et al. (1993) and Itoh et al. (1992). Unique mutant homo- and 
heteroduplex bands were observed in each case. Wild-type homoduplex is indicated by the arrow. 
FIGURE 3. Pedigree and and DGGE gel analysis of RET exon 10 from a family with MEN 2a. Direct 
DNA sequencing (not shown) revealed a thymine to adenine base substitution at nucleotide 2047 (Cys 
codon 618). Closed symbols indicate patients with MEN 2a. Unaffected individuals and spouses are 
indicated by the open symbols. All affected patients have histological evidence of MTC. Arrow. 
heteroduplexes generated from the mutant allele. 
dure simultaneously tests for all possible mutations 
at each of the five codons using identical gel con- 
ditions making it highly efficient and costaeffec- 
tive. The DGGE genotype can easily be identified 
in comparison with known mutant controls. Until 
greater experience is gained with our method, all 
mutations are confirmed by direct sequencing prior 
to diagnosis and treatment to ensure that the vari- 
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ations observed are not benign polymorphisms. We 
anticipate that this method will readily identify 
novel RET germline mutations in patients with 
familial disease or seemingly sporadic MTC. I t  has 
been estimated that missense changes in one of 
these five cysteines accounts for 97% of mutations 
in patients with MEN 2a and 86% of those ob- 
served in FMTC (Mulligan et al., 1994). There- 
fore, the DGGE approach described will not en- 
compass all possible MEN 2a/FMTC mutations. 
Optimization of the DGGE conditions for RET 
exon 13, another potential site in which FMTC 
mutations occur (Eng et al., 1995) is underway. 
We are currently testing the efficacy of the DGGE 
diagnostic strategy in our patients at risk for MEN 
2a or FMTC in a prospective ongoing clinical 
study. To date, discordancy between the DGGE 
results and findings at thyroid surgery has not been 
found (Decker et al., 1995). Based on our experi- 
ence, DGGE is a convenient, inexpensive, highly 
sensitive and reliable nonradioactive method 
which can be employed for rapid large-scale 
screening of patients at risk for RET MEN 2a and 
FMTC mutations. 
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